Natalia Ines Bomchil

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Compagnie Gervais Danone, Merial Limited. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalia Ines Bomchil. Retrieved from https://idiyas.com/inventor/natalia-ines-bomchil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Cachan, FR (2011)
Lyons, FR (2018 - 2022)

Company Filing History:

1 out of 94

Boehringer Ingelheim Animal Health USA Inc.

patents

1 out of 136

Compagnie Gervais Danone

4. 2 out of 834,513

Other

patents

Years Active: 2011-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11497802 - Live attenuated heterologous vaccine for (2022-11-15),

2. 10525117 - immunoprotective proteins and methods of identification and use thereof (2020-01-07),

3. 10363300 - FMDV and E2 fusion proteins and uses thereof (2019-07-30),

4. 9913891 - FMDV and E2 fusion proteins and uses thereof (2018-03-13),

5. 7981657 - Method for obtaining variants of lactic acid bacteria usable for producing vitamin K2 and application to the preparation of food products (2011-07-19),

Title: Natalia Ines Bomchil: Innovator in Vaccine Development

Introduction

Natalia Ines Bomchil is a prominent inventor based in Lyons, France. She has made significant contributions to the field of vaccine development, holding a total of 5 patents. Her work focuses on creating innovative solutions to enhance immunization against various infections.

Latest Patents

Among her latest patents is a live attenuated heterologous vaccine. This invention provides compositions or vaccines that contain a recombinant or an attenuated agent that elicits an immune response in animals against specific infections. Additionally, she has developed immunoprotective proteins and methods for their identification and use. These compositions and methods aim to elicit heterologous protective immunity in animals against multiple serovars of pathogens.

Career Highlights

Throughout her career, Natalia has worked with notable companies, including Boehringer Ingelheim Animal Health USA Inc. Her expertise in vaccine technology has positioned her as a key player in the field, contributing to advancements in animal health.

Collaborations

Natalia has collaborated with esteemed colleagues such as Jean-Christophe Francis Audonnet and Frédéric Reynard. These partnerships have further enriched her research and development efforts in vaccine innovation.

Conclusion

Natalia Ines Bomchil is a trailblazer in the realm of vaccine development, with a strong portfolio of patents and collaborations that underscore her impact on animal health. Her innovative work continues to pave the way for advancements in immunization strategies.

Profile summary based on public USPTO records.